Extent of vascular plaque predicts future cardiovascular events in patients with systemic lupus erythematosus
Open Access
- 28 April 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 62 (1) , 225-233
Abstract
Patients with SLE have increased prevalence of clinical cardiovascular disease (CVD) and subclinical atherosclerosis. Although 30–40% of patients with SLE have vascular plaque on ultrasound scanning, this study is the first to consider the relationship between total burden of plaque and subsequent CVD risk. One hundred patients with SLE and without any previous clinical CVD underwent vascular ultrasound scans of both carotid and both common femoral bifurcations between 2011 and 2013. Clinical, serological, demographic and treatment data were collected at baseline. Patients were followed till 2020 to identify those who developed new onset coronary disease or stroke. Statistical analysis to identify factors associated with increased risk of developing CVD events was carried out. Thirty-six patients had plaque at baseline. During follow-up five patients (all had baseline plaque) developed coronary disease and two, without baseline plaque, developed lacunar strokes. Mean (s.d.) age of these patients was 46.5 (4.5) years. Patients with three or more baseline bifurcations with plaque were 10 times more likely to develop CVD than those with 0–2 bifurcations with plaques (OR 9.9, P = 0.009). TPA > 16mm2 was associated with six-fold increased risk of CVD (OR = 6.44, P = 0.028). Patients with disease duration > 14 years were more likely than those with disease duration < 14 years to develop CVD (OR 8.3 P = 0.043) The number of bifurcations with plaque and TPA in patients with SLE may be valuable in assessing risk of CVD and deciding on clinical measures to reduce this risk.Keywords
Funding Information
- Rosetrees Trust and LUPUS UK
- Fundação para a Ciência e a Tecnologia (DFA/BD/7131/2020)
- LUPUS UK (1543411)
- National Institute for Health Research University College London Hospitals Biomedical Research Centre
This publication has 33 references indexed in Scilit:
- Use of atorvastatin in systemic lupus erythematosus in children and adolescentsArthritis & Rheumatism, 2011
- Lupus Atherosclerosis Prevention Study (LAPS)Annals of the Rheumatic Diseases, 2011
- Complement in atherosclerosis: friend or foe?Journal of Thrombosis and Haemostasis, 2011
- Numerical scoring for the BILAG-2004 indexRheumatology, 2010
- Dysfunctional proinflammatory high‐density lipoproteins confer increased risk of atherosclerosis in women with systemic lupus erythematosusArthritis & Rheumatism, 2009
- Association of high serum concentration of the third component of complement (C3) with pre-existing severe coronary artery disease and new vascular events in womenAtherosclerosis, 2004
- Lack of Complement Factor C3, but Not Factor B, Increases Hyperlipidemia and Atherosclerosis in Apolipoprotein E−/− Low-Density Lipoprotein Receptor−/− MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Cardiovascular risk assessment using ultrasound: the value of arterial wall changes including the presence, severity and character of plaquesPathophysiology of Haemostasis and Thrombosis, 2002
- Carotid Plaque, Intima Media Thickness, Cardiovascular Risk Factors, and Prevalent Cardiovascular Disease in Men and WomenStroke, 1999
- Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1997